Table 2.
Predictors of in-hospital all-cause mortality in Cancer Patients Admitted with Symptomatic COVID-19
| Multivariable Analysis | |||
|---|---|---|---|
| OR | 95% CI | p | |
| Age (per 10 years) | 1.43 | 1.22–1.67 | < 0.0001 |
| Female Gender | 0.59 | 0.44–0.79 | 0.001 |
| BMI (per 10 units) | 0.99 | 0.78–1.25 | 0.92 |
| Black Race* | 1.15 | 0.80–1.65 | 0.46 |
| Asian or Pacific Islander Race* | 1.43 | 0.80–2.53 | 0.22 |
| Undetermined or Other Race* | 1.05 | 0.66–1.70 | 0.83 |
| Diabetes | 1.13 | 0.82–1.57 | 0.45 |
| Hypertension | 1.34 | 0.88–2.04 | 0.17 |
| Hyperlipidemia | 1.12 | 0.81–1.53 | 0.50 |
| Smoking History | 2.63 | 1.54–4.48 | < 0.0001 |
| CKD | 0.85 | 0.60–1.20 | 0.35 |
| Pulmonary Disease | 1.47 | 1.03–2.09 | 0.033 |
| CVD History | 1.01 | 0.63–1.62 | 0.95 |
| Chemotherapy or Biologic Therapy | 1.72 | 1.05–2.80 | 0.030 |
*
As compared to Caucasian white race
BMI, Body Mass Index; CVD, Cardiovascular Disease; CI, Confidence Interval; CKD, Chronic Kidney Disease; OR, Odds Ratio.